These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 15163554)

  • 21. Mutation analysis of NR0B2 among 1545 Danish men identifies a novel c.278G>A (p.G93D) variant with reduced functional activity.
    Echwald SM; Andersen KL; Sørensen TI; Larsen LH; Andersen T; Tonooka N; Tomura H; Takeda J; Pedersen O
    Hum Mutat; 2004 Nov; 24(5):381-7. PubMed ID: 15459958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in the goat beta-lactoglobulin gene.
    Ballester M; Sánchez A; Folch JM
    J Dairy Res; 2005 Aug; 72(3):379-84. PubMed ID: 16174370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Rodríguez-Pérez JM; Zuñiga J; Granados J
    Immunol Lett; 2004 Aug; 95(1):31-5. PubMed ID: 15325795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
    Bayerer B; Stamer U; Hoeft A; Stüber F
    Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8.
    Stark K; Wongsud B; Burman R; Oliw EH
    Arch Biochem Biophys; 2005 Sep; 441(2):174-81. PubMed ID: 16112640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of two nucleotide substitutions and putative promoters in the 5' flanking region of the ovine IGF-I gene.
    Yilmaz A; Davis ME; Hines HCh; Chung H
    J Appl Genet; 2005; 46(3):307-9. PubMed ID: 16110188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
    Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
    Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class I chain-related gene B promoter polymorphisms and celiac disease.
    Rodriguez-Rodero S; Rodrigo L; Fdez-Morera JL; Martinez-Borra J; Lopez-Vázquez A; Fuentes D; Lopez-Arbesu R; Lopez-Soto A; Gonzalez S; Lopez-Larrea C
    Hum Immunol; 2006 Mar; 67(3):208-14. PubMed ID: 16698444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells.
    Pearce EG; Laxton RC; Pereira AC; Ye S
    Mol Cancer Res; 2007 Mar; 5(3):221-7. PubMed ID: 17339606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis.
    Rueda B; González-Gay MA; Mataran L; López-Nevot MA; Martín J
    Tissue Antigens; 2005 Jun; 65(6):544-8. PubMed ID: 15896202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the active site properties of CYP4F12.
    Eksterowicz J; Rock DA; Rock BM; Wienkers LC; Foti RS
    Drug Metab Dispos; 2014 Oct; 42(10):1698-707. PubMed ID: 25074871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant.
    Lo-Guidice JM; Allorge D; Cauffiez C; Chevalier D; Lafitte JJ; Lhermitte M; Broly F
    Pharmacogenetics; 2002 Jul; 12(5):367-74. PubMed ID: 12142726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of three new VNTR alleles in the promoter region of the TPMT gene.
    Alves S; Ferreira F; Prata MJ; Amorim A
    Hum Mutat; 2000 Jan; 15(1):121. PubMed ID: 10612847
    [No Abstract]   [Full Text] [Related]  

  • 34. Functional characterization of promoter region polymorphisms of human CYP2C19 gene.
    Satyanarayana Chakradhara Rao U; Devendran A; Satyamoorthy K; Shewade DG; Krishnamoorthy R; Chandrasekaran A
    Mol Biol Rep; 2011 Aug; 38(6):4171-9. PubMed ID: 21152987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of new mutations in the coding sequence and 5'-untranslated region of the human prostacylcin synthase gene (CYP8A1).
    Chevalier D; Cauffiez C; Bernard C; Lo-Guidice JM; Allorge D; Fazio F; Ferrari N; Libersa C; Lhermitte M; D'Halluin JC; Broly F
    Hum Genet; 2001 Feb; 108(2):148-55. PubMed ID: 11281454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of polymorphisms of canine Cytochrome P 450-CYP2D15.
    van Hagen MAE; Schipper L; Oosterveer-van der Doelen MAM; Vos-Loohuis M; Gehring R; Leegwater PA
    J Vet Pharmacol Ther; 2020 Nov; 43(6):602-607. PubMed ID: 32656886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural variation of the coding and non-coding human pharmacogenome.
    Tremmel R; Zhou Y; Schwab M; Lauschke VM
    NPJ Genom Med; 2023 Sep; 8(1):24. PubMed ID: 37684227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region.
    Cauffiez C; Klinzig F; Rat E; Tournel G; Allorge D; Chevalier D; Lovecchio T; Pottier N; Colombel JF; Lhermitte M; D'Halluin JC; Broly F; Lo-Guidice JM
    Biochem Pharmacol; 2004 Jun; 67(12):2231-8. PubMed ID: 15163554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human CYP4F12 genetic polymorphism: identification and functional characterization of seven variant allozymes.
    Cauffiez C; Klinzig F; Rat E; Tournel G; Allorge D; Chevalier D; Pottier N; Lovecchio T; Colombel JF; Lhermitte M; Lo-Guidice JM; Broly F
    Biochem Pharmacol; 2004 Dec; 68(12):2417-25. PubMed ID: 15548388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant.
    Cauffiez C; Lo-Guidice JM; Chevalier D; Allorge D; Hamdan R; Lhermitte M; Lafitte JJ; Colombel JF; Libersa C; Broly F
    Hum Mutat; 2004 Jan; 23(1):101. PubMed ID: 14695544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.